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THE ROLE OF PEYER’S PATCHES AND MESENTERIC LYMPH NODES IN
ACUTE GVHD: A STUDY GUIDED BY BIOLUMINESCENCE IMAGING IN
VIVO
Beilhack A.1, Schulz S.1, Wieland C.B.1, Beilhack G.F.1, Baker J.1,
Cao Y.-A.2, Herman E.I.1, Baker E.M.1, Contag C.H.2, Negrin, R.S.1
1. Dept. of Medicine, Div. of BMT Stanford University, Stanford, CA;
2. Dept. of Pediatrics, Stanford University, Stanford, CA.
Acute graft versus host disease (aGVHD) represents one of the
major obstacles in allogeneic bone marrow transplantation. Our
aim was to precisely determine the spatiotemporal evolution of
aGVHD in vivo, with special regard to the role of mucosa associ-
ated lymphatic tissues, particularly Peyer’s patches (PP), and mes-
enteric lymph nodes (mLN).
To visualize immune responses in living animals we developed
and characterized a luciferase expressing (luc) transgenic mouse
line (FVB/N, H-2Kq). Bioluminescence imaging (BLI) and lucif-
erase assays on puriﬁed transgenic donor cell populations revealed
luciferase expression in T, B, NK cells, granulocytes and macro-
phages. Recipient mice (Balb/c, H-2Kd) were total body irradiated
(800rads) and subsequently transplanted with 4 106 luc spleno-
cytes (Splc).
We detected the ﬁrst bioluminescent signals in PP and mLN
within 12 hours after transfer of luc allogeneic Splc. Using
triple-color immunoﬂuorescence microscopy (IFM), we could
show that the majority of inﬁltrating donor cells in PP consisted of
CD4 T-cells (80%). During these early time points (12h-day
2), the CD4 donor T cells were clearly restricted to parafollicular
T cell areas where they proliferated, while completely sparing B
cell follicles and subepithelial dome regions. On day 4 we observed
a rapid emigration of donor T cells from PP, which coincided with
enhanced mucosal inﬁltration of the small bowel, as shown by BLI.
These ﬁndings correlate well with the picture in mLN, where until
day 2 donor CD4 dominate over CD8 T cells. Signiﬁcant
changes in the CD4/ CD8 ratio in mLN occurred on day 4 where
up to 40 % of the donor T cells were CD8, while the cellularity
remained fairly high.
Experiments with syngeneic luc Splc showed preferential hom-
ing to the liver, but only transient migration to PP and mLN
without signs of proliferation at these sites. After day 4 syngeneic
luc Splc recipients displayed signs of hematopoietic engraftment.
In summary we showed that homing and proliferation of allo-
reactive CD4 donor lymphocytes in speciﬁc T cell areas of PP
and mLN are crucial events in aGVHD development. FACS anal-
ysis revealed distinct changes of the activation markers and homing
receptors of the alloreactive T cells. Furthermore BLI provided
valuable temporal and spatial guidance for more detailed analysis
by IFM and FACS of local environments and enabled us to pin-
point critical events in the induction and extension of aGVHD.
2
THE PARADOXICAL EFFECT OF GLUCOCORTICOID-INDUCED TUMOR
NECROSIS FACTOR RECEPTOR FAMILY-RELATED GENE (GITR) ACTIVA-
TION ON ALLOREACTIVE CD4 AND CD8 T CELLS AND THE DEVELOP-
MENT OF GVHD
Muriglan S.J., Ramirez-Montagut T., Alpdogan O., van Huystee T.,
Eng J.M., Hubbard V.M., Kochman A.A., Tjoe K.H.,
van Den Brink, M.R.M. Memorial Sloan-Kettering Cancer Center,
New York, NY.
GITR is a member of the tumor necrosis factor receptor family
and is involved in regulatory T cell function and TCR activation.
GITR is expressed at low levels on resting T cells, B cells and
macrophages. Upon activation, CD4 and CD8 T cells upregu-
late GITR expression while CD4CD25 regulatory T cells
(Treg) constitutively express GITR. Treg stimulation through
GITR inhibits their suppressor function and in vivo administration
of GITR agonistic antibodies induce autoimmune disease. Here we
show that GITR is a relevant molecule for immune responses in
graft-versus-host disease (GVHD) after allogeneic bone marrow
transplantation (allo BMT). We used a MHC class I/II disparate
model for murine allo BMT (C57BL/6 (B6) into BALB/c) to
determine the effects of a GITR activating antibody (GITR Ab) on
alloreactive T cells during the development of GVHD. We found
that addition of GITR Ab to a mixed lymphocyte reaction (MLR)
with irradiated BALB/c splenic stimulators, CD4CD25 B6
effectors and B6 Tregs induced the blockade of Treg suppressor
function, as previously described. Interestingly, GITR Ab also had
a direct effect on CD4CD25 and CD8CD25 T cell pop-
ulations. Addition of GITR Ab in an MLR showed a 2-fold de-
crease in CD4CD25 proliferation while CD8CD25 pro-
liferation increased by 3.5-fold when compared to the control. Fas
deﬁcient CD4CD25 T cells had an intact alloreactive prolif-
erative response, suggesting that GITR can induce Fas-mediated
apoptosis of CD4CD25 alloreactive T cells. We used the
adoptive transfer of CFSE-labeled donor CD3 T cells into irra-
diated allogeneic recipients to assess the expression of GITR in
vivo and found increased levels of GITR on both CD4 and
CD8 dividing alloreactive T cells. When we administered the
GITR Ab to allogeneic recipients of CD4CD25 or
CD8CD25 CFSE-labeled T cells, we observed a 45% reduc-
tion in the number of donor CD4CD25 CFSE-labeled T cells
recovered at day 3 after infusion. In contrast, there was a 54%
increase in the recovery of CFSE-labeled CD8CD25 T cells.
More importantly, mouse recipients of an allo BMT accompanied
by CD8CD25 donor T cells had increased morbidity and
mortality in the presence of GITR Ab. Conversely, mice treated
with GITR antibody that received allogeneic CD4CD25 T
cells in the allograft showed a signiﬁcant decrease in GVHD. Our
ﬁndings identify a novel and paradoxical effect of GITR stimula-
tion on alloreactive T cells during the development of GVHD.
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EXPANSION OF HUMAN UMBILICAL CORD BLOOD-DERIVED CD34STEM/
PROGENITOR CELLS TO TREAT MYOCARDIAL INFARCTION
Nagler A.1, Grynspan F.2, Peled T.2, Mandel J.2, Gutta E.3,
Holbova R.4, Feinberg M.4, Leor, J.4 1. Hematology, Cord Blood Bank,
Chaim Sheba Medical Center, Tel Aviv University, Tel Hashomer,
Tel-Aviv, Israel; 2. Gamida-Cell Ltd., Jerusalem, Israel; 3. Danek
Gertner Institute of Human Genetics, Chaim Sheba Medical Center, Tel
Hashomer, Tel-Aviv, Israel; 4. Neufeld Cardiac Research Institute.
Chaim Sheba Medical Center, Tel Aviv University, Tel Hashomer,
Tel-Aviv, Israel.
We aimed to test the hypothesis that ex-vivo expanded human
umbilical cord blood (CB)-derived Stem/Progenitor cells (S/P) can
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be used as a novel source for post myocardial infarction (MI)
healing and regeneration. S/P cells (CD34) were isolated from
CB of male newborns by the Miltenyi Biotec’s magnetic cell
separation device and expanded in the presence of a copper che-
lator and four early hematopoietic acting cytokines (SCF, TPO,
FLt-3 and IL6). Under these culture conditions the number of
CD34 cells increased by 31  6 fold and the early progenitor
(CD34CD38) cells increased by 409.2 148.9 fold, (n 9). An
MI model in athymic nude rats was used by permanent ligation of
the left anterior descending coronary artery (n  24). Ex vivo
expanded CB S/P cells (1  106 cells/rat) or saline (control) were
injected at the scar tissue one week post MI or infused IV at 48 h
after MI. By 4 weeks after cell therapy, the hearts were harvested
and representative sections were either ﬁxed or frozen sectioned.
The presence of human-donor cells in recipient hearts was con-
ﬁrmed by ﬂuorescent in situ hybridization (FISH) using deoxyri-
bonucleic acid probes speciﬁc for human X and Y chromosomes or
immunostaining for HLA-DR. HLA immunostaining revealed
that the ex vivo expanded human CB-derived donor cells engrafted
and colonized the infracted myocardium. Positive HLA staining
and Y signals were observed in vessel walls and cardiomyocytes,
suggesting differentiation or fusion of the human expanded CB
donor cells into vessel or myogenic cells. Representative slides
from control hearts were negative for both HLA and human sex
chromosomes. Blinded computerized image analysis of represen-
tative slides stained for smooth-muscle alpha-actin detected a
higher capillay and arteriole density (vessels/mm2) in the expanded
CB-scar-injected vs. control hearts (125  15 vs. 44  15/ mm2,
p 0.02). Serial echocardiographic studies before and 4 weeks post
cell therapy revealed that scar-injected ex vivo expanded CB cells
prevented LV dilatation accompanied by progressive LV dysfunc-
tion. Direct injection of S/P into the scar tissue was superior to that
of IV infusion as far as LV remodeling and function is concerned.
In conclusion, our data suggest that ex vivo expanded CD34 S/P
cells derived from human umbilical cord blood can engraft and
colonize the infracted myocardium. Moreover, this cell therapy
results in new vessel formation and prevention of LV dilatation and
myocardial dysfunction.
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